Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2

Life Sciences

Volumn 82, Issue 17-18, 2008, Pages 956-963

  Lu, Na ^a   Gao, Ying ^a   Ling, Yun ^a   Chen, Yan ^a   Yang, Yong ^a   Gu, Hong Yan ^a   Qi, Qi ^a   Liu, Wei ^a   Wang, Xiao Tang ^b   You, Qi Dong ^a   Guo, Qing Long ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Angiogenesis; Human gastric carcinoma; Tumor; VEGF; VEGFR2; Wogonin

Indexed keywords

CYCLOPHOSPHAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WOGONIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLAVANONES; FREE RADICAL SCAVENGERS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MICROTUBULES; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MUS MUSCULUS; SCUTELLARIA RADIX;

EID: 41749102871     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.02.013     Document Type: Article

References (49)

1. Ashton A.W., Yokota R., John G., Zhao S., Suadicani S.O., Spray D.C., and Ware J.A. Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2). Journal of Biological Chemistry 274 50 (1999) 35562-35570
2. Bernatchez P.N., Soker S., and Sirois M.G. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. Journal of Biological Chemistry 274 43 (1999) 31047-31054
3. Binetruy-Tournaire R., Demangel C., Malavaud B., Vassy R., Rouyre S., Kraemer M., Plouet J., Derbin C., Perret G., and Mazie J.C. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO Journal 19 7 (2000) 1525-1533
4. Chen Y.C., Shen S.C., Lee W.R., Lin H.Y., Ko C.H., and Shih C.M. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Archives of Toxicology (2002) 76351-76359
5. Chi Y.S., Cheon B.S., and Kim H.P. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochemical Pharmacology 61 10 (2001) 1195-1203
6. Chi Y.S., Lim H., Park H., and Kim H.P. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochemical Pharmacology 66 7 (2003) 1271-1278
7. Davis-Smyth T., Chen H., Park J., Presta L.G., and Ferrara N. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO Journal 15 18 (1996) 4919-4927
8. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of Clinical Oncology 20 21 (2002) 4368-4380
9. Ferrara N. Vascular endothelial growth factor. European Journal of Cancer 32A 14 (1996) 2413-2422
10. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nature Reviews Cancer 2 10 (2002) 795-803
11. Folkman J. Tumor angiogenesis: therapeutic implications. The New England Journal of Medicine 285 21 (1971) 1182-1186
12. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1 1 (1995) 27-31
13. Folkman J., and Klagsbrun M. Angiogenic factors. Science 235 4787 (1987) 442-447
14. Folkman S., and Chesney M. Grief. Vancouver conference review. AIDS Care 9 1 (1997) 39-43
15. Gao Z., Huang K., Yang X., and Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochimica Biophysica Acta 1472 3 (1999) 643-650
16. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 3 (1996) 353-364
17. Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell 80 2 (1995) 213-223
18. Hui K.M., Huen M.S., Wang H.Y., Zheng H., Sigel E., Baur R., Ren H., Li Z.W., Wong J.T., and Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochemical Pharmacology 64 9 (2002) 1415-1424
19. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. Journal of Clinical Investigation 52 11 (1973) 2745-2756
20. Kerbel R., and Folkman J. Clinical translation of angiogenesis inhibitors. Nature Reviews Cancer 2 10 (2002) 727-739
21. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362 6423 (1993) 841-844
22. Kimura Y., Okuda H., and Ogita Z. Effects of flavonoids isolated from Scutellariae radix on fibrinolytic system induced by trypsin in human umbilical vein endothelial cells. Journal of Natural Products 60 6 (1997) 598-601
23. Klagsbrun M., and D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine & Growth Factor Reviews 7 3 (1996) 259-270
24. Lee O.H., Kim Y.M., Lee Y.M., Moon E.J., Lee D.J., Kim J.H., Kim K.W., and Kwon Y.G. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 264 3 (1999) 743-750
25. Lee W.R., Shen S.C., Lin H.Y., Hou W.C., Yang L.L., and Chen Y.C. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochemical Pharmacology 63 2 (2002) 225-236
26. Li D.R., Hou H.X., Zhang W., and Li L. Effects of wogonin on inducing apoptosis of human ovarian cancer A2780 cells and telomerase activity. Ai Zheng 22 8 (2003) 801-805
27. Ling Y., Yang Y., Lu N., You Q.D., Wang S., Gao Y., Chen Y., and Guo Q.L. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells. Biochemical and Biophysical Research Communications 361 1 (2007) 79-84
28. Ma S.C., Du J., But P.P., Deng X.L., Zhang Y.W., Ooi V.E., Xu H.X., Lee S.H., and Lee S.F. Antiviral Chinese medicinal herbs against respiratory syncytial virus. Journal of Ethnopharmacology 79 2 (2002) 205-211
29. Macchiarini P., Fontanini G., Hardin M.J., Squartini F., and Angeletti C.A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340 8812 (1992) 145-146
30. Matthews W., Jordan C.T., Gavin M., Jenkins N.A., Copeland N.G., and Lemischka I.R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proceedings of the National Academy of Sciences of the United States of America 88 20 (1991) 9026-9030
31. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., and Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 6 (1993) 835-846
32. Ogawa S., Oku A., Sawano A., Yamaguchi S., Yazaki Y., and Shibuya M. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. Journal of Biological Chemistry 273 47 (1998) 31273-31282
33. Paley P.J., Staskus K.A., Gebhard K., Mohanraj D., Twiggs L.B., Carson L.F., and Ramakrishnan S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80 1 (1997) 98-106
34. Papapetropoulos A., Garcia-Cardena G., Madri J.A., and Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. Journal of Clinical Investigation 100 12 (1997) 3131-3139
35. Rafii S., Lyden D., Benezra R., Hattori K., and Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nature Reviews Cancer 2 11 (2002) 826-835
36. Risau W. Mechanisms of angiogenesis. Nature 386 6626 (1997) 671-674
37. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., and Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5 4 (1990) 519-524
38. Tai M.C., Tsang S.Y., Chang L.Y., and Xue H. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Reviews 11 2 (2005) 141-150
39. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., and Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochemical and Biophysical Research Communications 187 3 (1992) 1579-1586
40. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., and Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. Journal of Biological Chemistry 269 43 (1994) 26988-26995
41. Wang W., Guo Q., You Q., Zhang K., Yang Y., Yu J., Liu W., Zhao L., Gu H., Hu Y., Tan Z., and Wang X. Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721. Anticancer Drugs 17 7 (2006) 797-805
42. Wang W., Guo Q.L., You Q.D., Zhang K., Yang Y., Yu J., Liu W., Zhao L., Gu H.Y., Hu Y., Tan Z., and Wang X.T. The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo. Biological & Pharmaceutical Bulletin 29 6 (2006) 1132-1137
43. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Research and Treatment 36 2 (1995) 169-180
44. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. The New England Journal of Medicine 324 1 (1991) 1-8
45. Weidner N., Carroll P.R., Flax J., Blumenfeld W., and Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology 143 2 (1993) 401-409
46. Wu Z.Q., Guo Q.L., You Q.D., Zhao L., and Gu H.Y. Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biological & Pharmaceutical Bulletin 27 11 (2004) 1769-1774
47. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 6801 (2000) 242-248
48. Yu C.S., Yu F.S., Chuang Y.C., Lu H.F., Lin S.Y., Chiu T.H., and Chung J.G. Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells. Anticancer Research 25 1A (2005) 127-132
49. Zeng H., Dvorak H.F., and Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. Journal of Biological Chemistry 276 29 (2001) 26969-26979